Mapping the fallout of CMS' six-month hospice and home health moratorium

CMS implemented a six-month moratorium on hospice and home health enrollment on May 13, temporarily halting new providers from joining Medicare. The move was coordinated with a federal anti-fraud task force established in March and led by Vice President J.D. Vance, with formal support from the Department of Justice following in May.

The moratorium is the latest in a series of escalating enforcement actions aimed at curbing fraud, waste, and abuse in the Medicare hospice program. CMS framed it explicitly as a measure to stop new bad actors from entering the program while investigators work to identify and remove those already inside it. Still, there are impacts for compliant providers as well.

The lead up to the moratorium

The enrollment pause applies to new provider applications only. Hospices and home health agencies already enrolled and actively billing Medicare are not directly impacted by the moratorium itself.

But that's not the full picture.

The moratorium didn't happen in isolation. In the months leading up to it, CMS:

• Suspended payments to 773 hospices and 23 home health agencies in Los Angeles alone, representing $70 million in frozen funds tied to roughly $1.4 billion in Medicare spending
• Launched nationwide hospice site visits to verify that providers are operating as represented
• Introduced heightened oversight in states flagged as high-risk: Arizona, California, Georgia, Nevada, Ohio, and Texas.
• Expanded pre- and post-claim review demonstrations in Florida, Illinois, Oklahoma, Ohio, North Carolina, and Texas
• Deployed Unified Program Integrity Contractors (UPICs) — including Qlarant in the Western Jurisdiction — with significantly broadened investigative mandates

The moratorium is a headline. However, the scrutiny that drove this decision is the story that matters for existing providers.

The Enforcement Environment Has Structurally Changed

What's different about this moment is the coordination of anti-fraud investigations. CMS, DOJ, OIG, and the White House anti-fraud task force are now operating as a unified front. That means information flows faster, referrals move quicker, and investigations that previously might have taken years to materialize are being prioritized and accelerated.

For providers operating in high-scrutiny geographies — particularly California, Texas, and the other flagged states — the question is no longer whether heightened scrutiny will arrive. It's whether your documentation can hold up when it does.

And it's not just providers in high-risk states who need to pay attention. CMS explicitly designed the moratorium to be nationwide in scope to prevent fraudulent actors from simply relocating. That national posture carries through to the broader audit strategy: no geography is being treated as low-risk right now.

What Auditors Are Actually Looking For

When Medicare Administrative Contractors (MACs), UPICs, and Recovery Audit Contractors (RACs) review hospice claims under the current enforcement posture, they focus on a well-documented set of vulnerabilities:

Terminal prognosis documentation. OIG has specifically identified inadequate terminal prognosis support as a top audit target. Every certification needs specific, measurable clinical decline indicators — not templated language, not copied-forward notes.

Face-to-face encounter requirements. Missed or improperly documented F2F encounters are among the most common triggers for claim denial. Timing, attestation, and content requirements must all be met within CMS-mandated windows.

The "golden thread." Auditors look for narrative consistency across the CTI, nursing visit notes, and the plan of care. A note that doesn't connect to the broader clinical story — or that contradicts it — is a red flag that can unravel an otherwise defensible record.

Live discharge rates and length-of-stay patterns. High rates of live discharges, patients with unusually long stays, or beneficiaries who return to the same hospice within seven days all surface in CMS's new Service and Spending Variation Index (SSVI), the agency's newly launched public scoring system. A high SSVI score won't necessarily trigger an audit by itself, but it increases the likelihood of being selected for one.

Copy-paste documentation. CMS auditors are increasingly identifying generic, templated, or copy-forwarded notes as a compliance risk — particularly when they don't reflect the actual patient condition at the time of the visit.

The Strategic Takeaway for Existing Providers

The moratorium is aimed squarely at fraudulent actors — not compliant providers.

That said, the enforcement environment raises the stakes for everyone. Agencies with clean documentation and audit-ready records are well positioned to withstand heightened scrutiny. Those with documentation gaps should treat this moment as a prompt to close them — not because regulators are presuming guilt, but because the capacity and speed of review is increasing, and weaknesses that might have gone unnoticed in a lower-scrutiny environment are less likely to now.

There's also a less-discussed competitive dimension to this. As families and referral sources assess their hospice options during a period of high-profile fraud coverage, providers that can demonstrate transparency and compliance quality stand out. The agencies that navigate this period best won't just survive audits — they'll build the kind of documented track record that becomes a differentiator.

How Brellium Helps

The compliance challenge for most hospice organizations isn't a lack of good intentions. It's the sheer volume of documentation being produced across hundreds or thousands of patient visits — and the practical impossibility of manually reviewing all of it for the kind of consistency, completeness, and specificity that today's audit environment demands.

Brellium audits 100% of clinical documentation automatically — CTI documentation, face-to-face encounters, nursing visit notes — checked against Medicare Conditions of Payment and OIG audit criteria before billing, not after a denial arrives. When gaps are identified, providers get clear, actionable guidance on how to address them. The result is documentation that's consistent, defensible, and audit-ready at scale.

In an environment where the margin for error is this narrow, that's exactly where you want to be. See why industry leaders including Gentle Partners and Gentiva trust us to keep them audit-ready. Reach out today to book a demo and learn how we can help.